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The U.S. physician-scientist (PS) workforce is invaluable to the nation’s biomedical research 
effort. It is through biomedical research that certain diseases have been eliminated, cures for others 
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have been discovered, and medical procedures and therapies that save lives have been developed. 
Yet, the U.S. PS workforce has both declined and aged over the last several years. The resulting 
decreased inflow and outflow to the PS pipeline renders the system vulnerable to collapsing 
suddenly as the senior workforce retires. In November 2015, the Alliance for Academic Internal 
Medicine hosted a consensus conference on the PS workforce to address issues impacting 
academic medical schools, with input from early-career PSs based on their individual experiences 
and concerns. One of the goals of the conference was to identify current impediments in attracting 
and supporting PSs and to develop a new set of recommendations for sustaining the PS workforce 
in 2016 and beyond. This Article reports on the opportunities and factors identified and presents 
five recommendations designed to increase entry into the PS pipeline and nine recommendations 
designed to decrease attrition from the PS workflow.
The United States is currently the world’s leader in biomedical research,1 due in large 
measure to the contributions of the nation’s physician-scientist (PS) workforce.2–5 PSs are 
estimated to account for only 1.5% of the nation’s total physician workforce;5 however, they 
are invaluable to the nation’s biomedical research effort.5–13 Because of their training, PSs 
are a “vital force in transforming clinical observations into testable research hypotheses and 
translating research findings into medical advances.”10 It is through biomedical research that 
certain diseases have been eliminated, cures for others have been discovered, and medical 
procedures and therapies that save lives have been developed.1–3,14,15 Such discoveries have 
led to the lengthening of life spans, quality of life improvements, and the betterment of 
public health throughout the world.1–7,13–15
Importantly, the advances made thus far through biomedical research have positioned the PS 
workforce to make greater contributions to the enhancement of human health at an 
increasingly faster pace. The Human Genome Project, which began in 1989, changed the 
landscape for conducting research and ushered in an era of sharing data and using 
multidisciplinary approaches to address health issues.16 It also opened the doors to projects 
based on team science, big data, and precision medicine. As a result of these three 
initiatives, the PS workforce is able to implement large-scale, coordinated biomedical 
research programs, such as the Brain Research through Advancing Innovative 
Neurotechnologies Initiative, which is designed to better understand the brain and treat its 
disorders.4,17 Another example of this is the Precision Medicine Initiative Cohort Program, a 
longitudinal study of one million volunteers, which will enhance understanding of 
microbiome science, using mobile health technologies to better understand the 
pharmacogenetics of disease and empowering participants to improve their own health.4,18 
As a final example, there is the National Cancer Moonshot, which uses big data to accelerate 
the ability to prevent, detect, and treat all types of cancer.4,19
Concerns about sustaining the nation’s PS workforce have been publicly voiced by 
policymakers and others for the past four decades,5–13 and those concerns are growing in 
scope and intensity.5–13,20 The size of the PS workforce has declined over the past several 
years,5 as young physicians choose to focus their careers on being clinicians or clinician-
educators rather than PSs. Perhaps of even greater concern is the aging of the current PS 
workforce. During the ten-year period between 2003 and 2012, the number of PSs aged 60 
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or younger declined, while the number of those aged 61 or older rose (see Figure 1).5 These 
data are striking; they suggest (1) the entry and sustained engagement of new PSs into the 
workforce are in unprecedented decline and (2) senior members of the workforce have 
postponed retirement. In terms of a PS pipeline model, the decreased inflow and outflow 
renders the system vulnerable to collapsing suddenly as the senior workforce retires.
During 2007 and 2008, the Association of Professors of Medicine (APM) and the 
Association of American Medical Colleges (AAMC) held a series of conferences resulting 
in published and disseminated recommendations to expand the pool of funds to retain and 
foster the careers of young PSs, improve the approach for mentorship of young PSs, promote 
the advancement of women PSs, and identify and foster the career development of future 
PSs.12,13
In response to growing concerns about existing National Institutes of Health (NIH) support 
for PSs, in 2014, Director Francis Collins charged a Physician-Scientist Workforce Working 
Group to assess the current mechanisms of career support and make recommendations for 
improvement. In June 2014, the working group issued its report with a series of 
recommendations that, among other things, urged the NIH to sustain strong training of PSs, 
shift the balance in federally funded postdoctoral training for physicians to include more 
individual fellowships, continue to mitigate the gap in award rates between new and 
established investigators, and adopt rigorous tools to assess the strength of the PS workforce.
5
The working group also estimated, to maintain the nation’s current workforce of 
approximately 14,000 PSs, “about 1,000 individuals will need to enter the pipeline each 
year.”5 (This calculation assumes half of those who “enter the pipeline will not succeed.”)5 
This projection carries with it significant weight, since this could threaten the nation’s role 
as the global leader in biomedical research, as in 2015, Moses et al21 noted, if current trends 
continue, China will assume this role within the next ten years.
In November 2015, the Alliance for Academic Internal Medicine (AAIM) hosted a 
consensus conference, Re-examining the Physician Investigator Workforce: New and 
Evolving Areas of Research and Pathways to Success in Academic Institutions. The AAIM 
is a consortium of five organizations: the APM, Association of Subspecialty Professors, 
Association of Program Directors in Internal Medicine, Clerkship Directors in Internal 
Medicine, and Administrators of Internal Medicine. The focus of this conference was 
different than the charge given to the NIH Physician-Scientist Workforce Working Group—
that is, while the major concern of the working group was to address issues impacting NIH 
programs and policies, the major concern of the AAIM consensus conference was to address 
issues impacting academic medical schools, with input from early-career PSs based on their 
individual experiences and concerns.
The conference provided an opportunity for thought-leaders and early-career PSs to discuss 
a series of critical topics relating to the early identification of individuals with a potential for 
serious engagement in biomedical research, as well as optimal mechanisms for developing 
the careers of these individuals. Additionally, one of the goals of the conference was to 
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identify current impediments to attracting and supporting PSs and to develop a new set of 
recommendations for sustaining the PS workforce in 2016 and beyond.
More than 100 individuals attended the conference, representing a cross section of academic 
administrators, department chairs, program directors, and early-career PSs (see below), as 
well as representatives from national foundations, the NIH, the National Academy of 
Medicine, and the pharmaceutical industry. Fourteen early-career PSs attended the 
conference, representing ten academic medical centers. All of them were recipients of either 
an NIH mentored career development award or a Department of Veterans Affairs (VA) 
career development award. All of them were MDs, three had additional master’s-level 
degrees, and none had a PhD.
The conference included five plenary presentations on key topics to focus discussion during 
its ten breakout sessions. Each breakout session developed a series of recommendations 
targeted to academic health leaders and to the NIH and other funding agencies, with the goal 
of sustaining and potentially expanding the nation’s PS workforce. The recommendations 
from each breakout session were then presented to all of the conference attendees. Although 
there were slight differences of opinion among the conference participants on certain 
recommendations, the recommendations included in this article are those on which the 
conference reached unanimous consensus and which were subsequently approved by the 
AAIM Board of Directors. These recommendations are categorized within two major 
strategies: (1) increasing entry into the PS pipeline and (2) reducing attrition from the PS 
workforce (see List 1).
For the purposes of this consensus statement, PSs were defined as physicians who devote the 
majority of their professional effort to a defined area within the broad continuum of 
biomedical research (inclusive of basic, translational, clinical, epidemiological, outcomes, 
and medical educational research) conducted in academic institutions, government agencies, 
industry, and independent research centers and institutes. Many of these individuals have a 
professional degree in the sciences, in addition to an MD, and continue to provide patient 
care in their capacity as clinicians.
Opportunities for Increasing Entry Into the PS Pipeline
Developing and implementing strategies to increase the number of PSs in the U.S. workforce 
is essential. Opportunities to achieve this goal include facilitating better and early promotion 
of the value of biomedical research, increasing the diversity of the PS workforce, using role 
models and mentors to increase diversity, and streamlining the PS training process and 
expanding research training opportunities.
Facilitating better and early promotion of the value of biomedical research
It is important to promote the value of biomedical research as early as elementary school—
while children’s brains are still being developed. Despite a focus on implementing programs 
to increase students’ skills in science, technology, engineering, and mathematics (STEM), 
the United States is not ranked in the top 20 on science scores from standardized tests 
among industrialized nations.22 Allen and Kamen23 argue this low ranking can, in part, be 
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attributed to the nation as a whole placing greater value on its athletes and entertainers than 
it does on research and innovation. Collaborations between government agencies, 
community-based organizations, private-sector research organizations, and schools are 
necessary to effectively promote both the value of biomedical research and the goals of 
existing STEM programs.
Increasing the diversity of the PS workforce
Data compiled by the AAMC demonstrate a lack of diversity in the PS pipeline. In 2015, 
women accounted for 47.8% of those matriculating into medical school;24 however, for each 
of the past five years, they have consistently accounted for between 37% and 38% of those 
enrolled in the nation’s MD/PhD programs.25 The lower representation of women in the 
MD/PhD pipeline reflects both fewer female applicants to start with and greater levels of 
attrition among women.26–28 There are several factors reported by women as to why they are 
less likely to pursue the MD/PhD career path, which include concerns about child rearing or 
other family responsibilities; a sense of bias in the workplace resulting in the perception that 
there is a need to “outcompete” relative to male counterparts; encountering, on multiple 
fronts, a lack of encouragement to become a PS; and a lack of role models.27–31
The pipeline for racial/ethnic underrepresented groups also needs to be expanded.8,32 Of the 
616 graduates of MD/PhD programs in the United States during the 2014–2015 academic 
year, only 79 (12.8%) reported themselves as being from a racially/ethnically 
underrepresented group: 26 (4.2%) self-identified as black or African American; 12 (1.9%) 
as Hispanic, Latino, or of Spanish origin; and 41 (6.7%) as multiple race/ethnicity.33
Additionally, while large numbers of talented and aspiring PSs from other countries attempt 
to enter research training in the United States, only a small percentage of them are 
successful in entering the nation’s PS workforce.5 Of the 626 matriculates to the nation’s 
MD/PhD programs in 2015, only 16 (2.6%) came from countries outside the United States.
34
 This small number of international matriculates can be partially explained by funding 
restrictions imposed on slightly less than one-half of the nation’s MD/PhD programs—that 
is, the federally funded Medical Scientist Training Programs (MSTPs) are open only to U.S. 
citizens and permanent residents of the United States. Facilitating the recruitment and 
retention of members from diverse populations, including efforts to enhance opportunities 
for international students to enter and remain in the United States, could be an effective 
strategy for increasing the PS workforce.
Using role models and mentors to increase diversity
Role models and mentors function differently, and both are important to increasing entry 
into the PS pipeline. Role models, according to Cruess et al,35 can “inspire and teach by 
example.” Role models can be, for example, sports heroes, celebrities, or PSs, and their 
impact on others can occur in an elementary school classroom as easily as on a television 
show or during a Grand Rounds lecture.
Exposure to role models is key. Qualitative research of racially/ethnically underrepresented 
high-school students revealed many had never had interactions with a PS.30,36 They voiced 
this as an underlying reason for why they did not consider a research career. Furthermore, 
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similar research conducted on MD/PhD medical students indicated exposure to role models 
as early as middle- and/or high-school influenced their decisions to enter a research career.
5,36
 Students spoke of the role models they encountered during their science courses, 
exposure to PSs in their families, and exposure to professionals during a family health crisis. 
These studies emphasize the critical importance of role models in addressing racial/ethnic 
disparities in the MD/PhD pipeline.
Mentors differ from role models, according to Paice et al,37 in that a “mentor is actively 
engaged in an explicit two way relationship” with a trainee or a less-experienced colleague. 
It is “a relationship that evolves and develops over time and can be terminated by either 
party.”37 Programs such as the National Research Mentoring Network (NRMN) exist to 
offer mentoring not only in specific areas of inquiry but also in areas of professional 
development. Some of the NRMN’s programs “emphasize the benefits and challenges of 
diversity, inclusivity and culture within mentoring relationships, and more broadly the 
research workforce.”38
Streamlining the PS training process and expanding research training opportunities
Preparation for a career in biomedical research is a lengthy process requiring well over a 
decade of undergraduate, medical school, and postgraduate training, which may include 
formal graduate education in a scientific discipline. To expedite this process, combined 
MD/PhD curricula (including federally funded MSTPs) were developed with the idea of 
better integrating and expediting medical and research training during medical school. The 
results of a national survey from 2014 show these programs have had success with >80% of 
MD/PhD program graduates pursuing research-oriented careers.39 As an alternative to 
MSTP enrollment (a commitment of over seven years),39 a subset of medical students take 
advantage of formal research tracts, which offer enrollees a one-year mentored research 
experience during medical school (with institutional or external funding support). Limited 
anecdotal data supports the effectiveness of some of these formal research tracts.40,41
After gaining research experience in medical school, many graduates opt to complete their 
professional education with a lengthy period of postgraduate clinical and research training. 
To expedite this process, supplemental mechanisms have been developed to streamline this 
postdoctoral experience. One such approach, sanctioned by the American Board of Internal 
Medicine, is a residency research pathway which combines expedited clinical training (and 
often subspecialty fellowship) with three years of mentored postdoctoral research. Despite a 
shortened duration of clinical training (two years instead of three), the clinical competency 
(as measured by board exam pass rate) of these graduates was not sacrificed,42 and more 
than 80% went on to pursue funded biomedical research.43 Other medical specialty boards 
(e.g., pediatrics and pathology) have sanctioned similar streamlined postdoctoral training 
pathways. Finally, since not all physicians with a budding interest in research have 
completed graduate-level scientific training prior to or during medical school, several 
research-intensive medical schools have developed formal postdoctoral research training 
programs (often leading to a MS or PhD degree) to provide this rigorous training to a select 
group of committed physicians who are in the later stages of clinical training or who are 
junior faculty.44–46
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Recommendations Aimed at Increasing Entry Into the PS Pipeline
The AAIM consensus conference recommendations for increasing entry into the PS pipeline 
were to (1) promote to young people the value of biomedical research and the important and 
unique role that PSs play in biomedical advances; (2) facilitate the recruitment and retention 
of members from diverse populations as PSs through wide-scale implementation of 
programs that provide access to a network of role models and mentors; (3) enhance 
opportunities for international PSs to enter and remain in the United States as members of 
the nation’s workforce; (4) promote efficiency and curricular best practices in the training of 
PSs; and (5) enhance undergraduate and postgraduate research training opportunities for 
trainees who do not matriculate into MD/PhD programs (List 1).
Promote to young people the value of biomedical research and the important and unique 
role that PSs play in biomedical advances
Innovative educational interventions should be established to provide enrichment in science 
and math as well as to provide support for young learners, especially those from 
disadvantaged backgrounds. To this end, collaborations between government agencies, 
community-based organizations, private-sector research organizations, and schools should 
be encouraged.
Facilitate the recruitment and retention of members from diverse populations as PSs 
through wide-scale implementation of programs that provide access to a network of role 
models and mentors
Creating a network of role models, comprising PSs and other professionals, to routinely visit 
K–12 and undergraduate classes would help expose students to the value of biomedical 
research and its viability as a career. Similarly, programs such as the NRMN should be 
widely used to recruit and retain members from diverse populations as they pursue training 
as a PS.
Enhance opportunities for international PSs to enter and remain in the United States as 
members of the nation’s workforce
Research awards and grants are frequently dependent on residency status. Universities 
sponsoring foreign medical school graduates’ postdoctoral studies should provide assistance 
with applications for permanent residence in the United States. Additionally, the NIH should 
work with other government agencies to amend policies on eligibility requirements for its 
National Research Service Award fellowships, training grants, and career development 
awards to include graduates of foreign medical schools who have been admitted to the 
United States for postgraduate study but who have not yet been granted permanent resident 
status.
Promote efficiency and curricular best practices in the training of PSs
Trainees who have demonstrated a commitment to careers in research should be strongly 
encouraged to take full advantage of educational initiatives that shorten and streamline the 
training process, such as formal MD/PhD programs during medical school and coordinated 
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residency/subspecialty research pathways during postgraduate training. Continued NIH 
funding for MSTPs should be provided.
Enhance undergraduate and postgraduate research training opportunities for trainees who 
do not matriculate into MD/PhD programs
Medical students who have an interest in research but who are not enrolled in a formal 
MD/PhD program should consider participating in a one-year mentored research experience. 
Clinically trained physicians who develop an interest in pursuing research later in their 
professional education (e.g., subspecialty fellowship) or as junior faculty should consider 
participating in formal research training opportunities that may lead to a master’s and/or 
doctoral degree. Currently, there is limited published data on the effectiveness of these 
undergraduate and postgraduate training programs,40,41,44–46 so comprehensive surveys of 
these alternative research curricula (including content, mechanisms of support, and career 
outcomes of graduates) should be conducted by relevant professional organizations, such as 
the AAIM or AAMC, and a mechanism for program leaders to convene and exchange best 
practices should be provided.
Factors to Address to Reduce Attrition From the PS Workforce
Many PSs, especially those in the early and middle stages of their careers, leave behind their 
original plans to pursue biomedical research opportunities to enter full-time clinical practice. 
Reasons for attrition are numerous and complex; however, there are identifiable factors that 
can be causally linked to the attrition of PSs from academia, including inadequate 
mentoring, a narrow perception of success as a PS, increasing competition for external 
support, financial pressures, inadequate institutional support, and difficulties with work-life 
balance.
Inadequate mentoring
Achieving success as an independently funded PS can be challenging. Strong, active 
mentoring is a crucial element of that success.43 While the mentor-apprentice dyad has been 
the traditional model of mentorship, several institutions have developed initiatives designed 
to provide centralized oversight, mentorship support, and career development. Established 
researchers, while having the expertise to perform research, may require additional 
educational support to develop the skillset needed to actively mentor an apprentice. Training 
programs for research mentors have been shown to be effective.47–49 Such programs should 
be implemented in all medical schools and should include formalized training in areas such 
as career negotiation, grant-writing, publication of manuscripts, and work-life balance.47 
Home institutions, the NIH, and other funding agencies should allocate adequate resources 
to mentors in terms of both time and compensation.
A narrow perception of success as a PS
A widely-held view is that a successful PS is funded by the NIH as a principal investigator 
for bench or early translational research.50 This notion does not take into account the 
broader definition of a PS as posited by the NIH and others5 nor does it take into account the 
evolution occurring within the research arena that requires multidisciplinary research teams 
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to use big data and advance precision medicine initiatives. Nonetheless, these antiquated 
notions of what constitutes a successful PS continue to pose the possibility of negative 
career consequences when it comes to decisions about research funding and promotion and 
tenure (P&T). Accordingly, both funding agencies and academic medical centers will need 
to develop broader criteria for what constitutes success as a PS.50
Increasing competition for external support
The first-time award rate among PSs for an NIH-funded R01 grant was 14% in 2012, an all-
time low.5 The process to receive a grant from the NIH has become more competitive, with 
overall success rates for all research project grants dropping from 31% in 1997 to 18% in 
2014.5 The failure to successfully obtain or continue funding is a common and unpredictable 
occurrence. The resulting sense of researcher vulnerability, as compared to other career 
pathways, can contribute to attrition. It makes a strong case for the NIH to establish a 
program similar to its K99/R00 Pathway to Independence Award initiative to facilitate PSs 
during their transition from training to an independent research career.
Academic institutions need to consider partnering with other sources of funding, such as 
federal and state agencies, professional associations and societies, and the private-sector, 
including the pharmaceutical industry. With the growth of big data, opportunities also exist 
to partner with companies such as Google and Amazon. Effective mentorship and career 
development will be needed to provide PSs with the knowledge and tools to be able to 
access these diverse funding sources.
Financial pressures
During both medical school and postgraduate training, there is a financial disincentive to 
pursue a PS career relative to a career in clinical practice—that is, there is the potential for a 
much greater burden of educational debt and a significant delay in eligibility for stable, paid 
employment.7,51,52 Even if an MD/PhD student is supported through a fellowship, the 
significant duration of medical school training (seven years or longer), coupled with 
incremental postdoctoral research training, is sufficient to sway all but the most committed 
young scientists away from a career in biomedical research. In a best-case scenario, a PS 
becomes a candidate for a tenure-track position at the age of 36.5 However, many PSs retain 
their postdoctoral status for several additional years because the demand for tenure-track 
positions exceeds the supply.52 Often, their employment and appointment as assistant 
professor is formally or informally contingent on successful funding from the NIH (such as 
a K or R award), yet the average age of PSs with an MD receiving their first R01 is 43.8 
years, for those with an MD/PhD the average age is 44.3 years.5 Many PSs have large debt 
burdens when beginning their first faculty appointment, a situation that creates substantial 
financial duress and does not provide the means for the stable support of a family.
Inadequate institutional support
Institutional support can take several forms, and is often the result of the unique needs of 
PSs when compared to others, such as clinicians or PhD researchers. PSs are asked to 
generate increasing amounts of clinical revenue, which affects the time they can spend on 
their research or apply to securing research funding.52 Similarly, PSs are often paid less than 
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their clinician counterparts and are often expected to obtain a large portion of their salary, 
and the salaries of others on their research team, through external funding. Unfortunately, 
their home institutions are often not optimally forthcoming with bridge funding when lapses 
of external funding occur.7 Finally, the metrics for P&T for PSs are often outdated and fail to 
take into account contributions to team science, the ever-increasing length of time needed to 
establish a career as an independent PS, or the demands that will need to be met within the 
arenas of big data, precision medicine, and team science.
Difficulties with work-life balance
PSs are generally entering the workforce at a time when many of them are also starting 
families. Episodic noncareer responsibilities (e.g., family and health issues) can often 
demand that PSs temporarily remove themselves from the workforce. PSs’ home institutions 
need to accommodate the competing demands that work and family often present, provide 
flexible options whenever possible, and assure the career trajectory of their PS faculty are 
not adversely affected as a result. Generational differences may lead to work environments 
that are unappealing to junior faculty. For example, individuals now entering medical school 
and those entering academia as junior faculty increasingly value a balance between work and 
life. Supporting this value system, studies have demonstrated that achieving a work-life 
balance can reduce stress, emotional exhaustion, and burnout.47,53,54
Recommendations Aimed at Reducing Attrition From the PS Workforce
The AAIM consensus conference recommendations for reducing attrition from the PS 
pipeline were to (1) implement formalized mentoring programs, including “mentoring the 
mentor” training, and periodic reviews of mentoring results; (2) establish grant programs 
specifically targeted to supporting the PS transitioning from training to an independent 
research career; (3) expand student loan repayment opportunities for individuals who are 
awarded an NIH or a VA career development grant; (4) provide salary support for mentors 
named on career development awards; (5) assure department-wide salary equity among PSs; 
(6) provide a stable environment for PS faculty to become independent researchers through 
provision of protected time and, when necessary, bridge funding; (7) reconsider criteria for 
P&T to accommodate the changing environment for PSs’ contributions to biomedical 
advances and be transparent in P&T decision-making processes; (8) pursue new avenues for 
research and research funding, including expanding partnerships with industry; and (9) 
establish a repository for PS career development data (List 1).
Implement formalized mentoring programs, including “mentoring the mentor” training, and 
periodic reviews of mentoring results
Formalized mentoring programs may help not only the protégé; they may also ultimately 
enhance the reputation of the institution through the successes of its faculty. Team-based, 
multigenerational, multi-institutional, and multicultural mentoring groups, therefore, could 
have a wide-reaching and positive impact on an institution’s junior faculty members. 
Mentoring topics should cover several areas; in addition to specific research topics, 
mentoring should be provided on the responsible conduct of research, grant-writing, 
publication of manuscripts, leadership, career negotiation, and work-life balance. Training of 
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mentors and periodic evaluations of mentoring results should be required components of an 
institution’s mentoring program.
Establish grant programs specifically targeted to supporting the PS transitioning from 
training to an independent research career
Periods of transition are a particularly vulnerable time for young PSs, and the period when a 
PS is transitioning from training to an independent research career is one in which attrition 
may be more likely occur. The NIH must set aside funds specifically designated for PSs with 
the purpose of protecting them in this transition phase, similar in nature to the current 
K99/R00 program. NIH study sections need to recalibrate their expectations to 
accommodate highly promising individuals who may not have amassed a large body of 
preliminary data.
Expand student loan repayment opportunities for individuals who are awarded an NIH or a 
VA career development grant
Many PSs have amassed large amounts of student loan debt, which can factor into their 
decision to leave academia for a more lucrative profession. NIH loan repayment programs 
are designed to help recruit and retain highly qualified health professionals into biomedical 
research careers. Participants in these loan repayment programs have been shown to remain 
in research careers longer, apply for and receive more research grants, and be more likely to 
become independent investigators.55 Loan repayment opportunities for these individuals 
should be enhanced.
Provide salary support for mentors named on career development awards
Young investigators with mentored career development awards note they often overreport the 
time spent with their mentors to their funding agency,5 mainly because their mentors’ other 
commitments sometimes take precedence over their mentoring needs. The NIH and other 
funding agencies need to recognize the important and time-consuming role that mentors play 
in the development of young investigators looking to establish independent research careers. 
Mentors should be compensated for their time and allowed to formally record the percentage 
of time spent mentoring when reporting on their levels of effort and productivity.
Assure department-wide salary equity among PSs
It is widely recognized that salary equity remains unresolved in several of the nation’s 
medical schools, with gender as the highest source of disparity.56,57 Department chairs 
should be transparent in their salary policies, discuss salary distribution and start-up 
packages when offering a salaried position to a PS, and report salary distributions to 
department faculty on a periodic basis thereafter.
Provide a stable environment for PS faculty to become independent researchers through 
provision of protected time and, when necessary, bridge funding
The career development of a PS is a long-term investment; income generation usually 
increases only after a latency period that is measured in years. Department chairs and their 
institutions must embrace a broad vision of the function and trajectory of the young PS and 
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construct a long-term budget that reflects this delay. This may include providing mentorship 
oversight, career development programming, grant reviews, and funding support for the 
transition from fellow to faculty.58 The expectation that new PS faculty members can 
generate clinical revenue sufficient to support their salaries while simultaneously developing 
their research careers is unrealistic. Additionally, department chairs should actively consider 
providing flexible options to accommodate their PS faculty members’ long-term work-life 
balance.
Reconsider criteria for P&T to accommodate the changing environment for PSs’ 
contributions to biomedical advances and be transparent in P&T decision-making 
processes
Team-based research must be valued appropriately in P&T deliberations. Traditionally, 
individual research has been the gold standard; however, team-based research is becoming 
increasingly common and more important in an era where advancement of knowledge 
requires the contributions of multiple disciplines. In support of the current direction of 
research, P&T committees must develop policies that recognize a researcher’s status as an 
indispensable contributor and consider a successfully funded grant proposal as evidence of 
scholarship regardless of who is named as the principal investigator. Within the model of 
team science research, competition for first-author position on a publication should be 
deemphasized. Finally, P&T considerations for PSs needing additional time for promotion 
and the award of tenure should be provided without penalty.
Pursue new avenues for research and research funding, including expanding partnerships 
with industry
Although the NIH provides the majority of research support for PSs, it should not be 
considered the only source of support. In addition to other federal and state agencies, private 
and public foundations, professional societies and associations, industry, and foreign sources 
are often willing to fund research. As big data initiatives become more commonplace, 
institutions would be well-served to accommodate partnerships that can be mutually 
beneficial.
Establish a repository for PS career development data
There is a paucity of data with which to make rational plans for improvement in the research 
career development process for PSs. A data repository would provide a strong foundation for 
future decisions. At a minimum, the repository should include (1) a description of training 
pathways used, (2) external grant applications, (3) external grants successfully funded, and 
(4) appointment and employment data for PSs collected for a period of at least five years 
after completion of all training.
Summary
The proper valuing of the PS workforce is critical to maintaining the status of the United 
States as the world leader in biomedical research. Moving forward, academic institutions, 
the government, and the private sector must work together to promote the general field of 
biomedical research as a career option through the enhancement of science and math 
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curricula in the K–12 education system and the promotion of the PS as a career choice to 
diverse groups that are currently underrepresented in the workforce.
Academic medicine must also embrace the new ways in which biomedical advances are 
achieved by fostering team science, big data, and precision medicine, and establishing 
mechanisms for researchers involved in these initiatives to be recognized. Measures must be 
implemented to support young PS faculty through strong, viable mentorship programs and 
the provision of the support necessary to establish desirable independent research careers. 
Academia must create and oversee efficient career tracks that encourage interested young 
physicians to pursue a research pathway and provide robust levels of support so that all 
career pathways will flourish. Finally, new and creative partnerships with industry and other 
sources could help fund biomedical advances.
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Figure 1. 
Numbers and percentage changes of the U.S. physician-scientist workforce by age group, 
2003–2012. Adapted from Chapters 2 and 3 of National Institutes of Health, Physician-
Scientist Workforce (PSW) Report 2014 (available at http://report.nih.gov/workforce/psw/
index.aspx).
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List 1
Recommendations of the Alliance for Academic Internal Medicine Consensus Conference on the PS 
Workforce, November 2015
Increasing entry into the PS pipeline
1 Promote to young people the value of biomedical research and the important and unique role that PSs play in biomedical 
advances.
2 Facilitate the recruitment and retention of members from diverse populations as PSs through wide-scale implementation of 
programs that provide access to a network of role models and mentors.
3 Enhance opportunities for international PSs to enter and remain in the United States as members of the nation’s workforce.
4 Promote efficiency and curricular best practices in the training of PSs.
5 Enhance undergraduate and postgraduate research training opportunities for trainees who do not matriculate into MD/PhD 
programs.
Reducing attrition from the PS workforce
1 Implement formalized mentoring programs, including “mentoring the mentor” training, and periodic reviews of mentoring 
results.
2 Establish grant programs specifically targeted to supporting the PS transitioning from training to an independent research career.
3 Expand student loan repayment opportunities for individuals who are awarded an NIH or a VA career development grant.
4 Provide salary support for mentors named on career development awards.
5 Assure department-wide salary equity among PSs.
6 Provide a stable environment for PS faculty to become independent researchers through provision of protected time and, when 
necessary, bridge funding.
7 Reconsider criteria for P&T to accommodate the changing environment for PSs’ contributions to biomedical advances and be 
transparent in P&T decision-making processes.
8 Pursue new avenues for research and research funding, including expanding partnerships with industry.
9 Establish a repository for PS career development data.
Abbreviations: PS indicates physician-scientist; NIH, National Institutes of Health; VA, Department of Veterans Affairs; P&T, promotion and 
tenure.
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